H. Zu

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

H. Xiang, Xianghui Qi, Jing-wen Ai, 2022, Hepatology International.

Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study

H. Xiang, Yan Yan, Wenhong Zhang, 2021, Clinical Gastroenterology and Hepatology.

Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study

H. Xiang, Xianghui Qi, Chuan Liu, 2022, Journal of medical virology.

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysis

Xianghui Qi, Xuefeng Luo, Xinwei Han, 2023, Portal Hypertension & Cirrhosis.